Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 8 Fatigue 6 Breast Neoplasms 5 Anxiety Disorders 3 Psychological Well-Being 2 Pain 2 Lung Neoplasms 2 Gastrointestinal Neoplasms 2 Esophageal Neoplasms 2 Depression 2 Caregiver Burden 2 Uterine Neoplasms 1 Tuberous Sclerosis 1 Substance-Related Disorders 1 Smoking Cessation 1 Sleep Wake Disorders 1 Sleep Initiation and Maintenance Disorders 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Pain, Postoperative 1 Ovarian Neoplasms 1 Neurofibromatosis 1 1 Neurofibroma, Plexiform 1 Neoplasm Regression, Spontaneous 1 Multiple Myeloma 1 Malignant Hepatobiliary Neoplasm 1 Lymphoma 1 Leukemia 1 Hematopoietic Cell Transplantation Recipient 1 Head and Neck Neoplasms 1

Interventions

Everolimus 18 Sirolimus 15 Cannabidiol 6 radiprodil 3 ganaxolone 3 Vigabatrin 3 Activator Appliances 3 Melatonin 2 exemestane 1 dactolisib 1 carbon-11 acetate 1 Urination 1 Surveys and Questionnaires 1 Surgical Procedures, Operative 1 Solutions 1 Simvastatin 1 Sertraline 1 Selective Serotonin Reuptake Inhibitors 1 Propranolol 1 Phlebotomy 1 Itraconazole 1 Injections 1 Genetic Testing 1 Fluid Therapy 1 Doxycycline 1 Curcumin 1 Carbamazepine 1 Calcitriol 1 Aspirin 1 Anticonvulsants 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Tuberous Sclerosis × Acceptance and Commitment Therapy × Clear all

NCT05867576 2024-02-14

ACT in TSC

University Hospitals Bristol and Weston NHS Foundation Trust

Phase NA Unknown

Psychological Well-Being, Tuberous Sclerosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡